RMD Open (Aug 2020)
How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers
- Bente Glintborg,
- Johan Askling,
- Katerina Chatzidionysiou,
- Lene Dreyer,
- Thomas Frisell,
- Kalle Aaltonen,
- Bénédicte Delcoigne,
- Merete L Hetland,
- René Cordtz,
- Kristian Zobbe,
- Nina Trokovic,
- Sella Aarrestad Provan
Affiliations
- Bente Glintborg
- 1 The DANBIO registry and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopaedics, Rigshospitalet Glostrup, Glostrup, Denmark
- Johan Askling
- Division of Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- Katerina Chatzidionysiou
- st Department of Propaedeutic and Internal Medicine, Joint Rheumatology Program, Laiko Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece
- Lene Dreyer
- Department of Rheumatology, Aalborg University Hospital, Aalborg, Denmark
- Thomas Frisell
- Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska Institutet Department of Medicine Solna, Stockholm, Sweden
- Kalle Aaltonen
- Pharmaceuticals Pricing Board, Ministry of Social Affairs and Health, Helsinki, Finland
- Bénédicte Delcoigne
- Division of Clinical Epidemiology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden
- Merete L Hetland
- DANBIO and Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Centre of Head and Orthopedics, Rigshospitalet, Copenhagen, Denmark
- René Cordtz
- Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte Hospital, The Parker Institute, Frederiksberg Hospital Parker Institute, Frederiksberg, Denmark
- Kristian Zobbe
- Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte Hospital, The Parker Institute, Frederiksberg Hospital Parker Institute, Frederiksberg, Denmark
- Nina Trokovic
- Helsinki University and Hospital (ROB-FIN), Departments of Medicine and Rheumatology, Helsinki University Central Hospital, Helsinki, Finland
- Sella Aarrestad Provan
- Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway
- DOI
- https://doi.org/10.1136/rmdopen-2020-001363
- Journal volume & issue
-
Vol. 6,
no. 2
Abstract
No abstracts available.